Helocyte's Debt Round

Helocyte raised a round of funding on July 15, 2016.

Helocyte, formerly DiaVax Biosciences, is a clinical-stage company developing novel immunotherapies for the prevention and treatment of cancer and infectious disease (and in particular, cytomegaloviru…

Articles about Helocyte's Debt Round: